Published in

American Association for the Advancement of Science, Science Advances, 18(6), 2020

DOI: 10.1126/sciadv.aaz7001

Links

Tools

Export citation

Search in Google Scholar

RasGRP1 is a causal factor in the development of l-DOPA–induced dyskinesia in Parkinson’s disease

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

A novel molecular target that signals abnormal involuntary movement in Parkinson’s disease treatment is discovered.